Company: BWAY
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001171843-25-002347
Chunk: 84

Company: Brainsway Ltd.
Filing Date: 2025-04-22
Form: 20-F
Item: Item 5
Chunk 84
---
 on The Nasdaq Global Market. However, we may in the future decide to use the foreign private issuer exemption
with respect to some or all of the other Nasdaq corporate governance rules. Following our home country governance practices as opposed
to the requirements that would otherwise apply to a U. S. company listed on The Nasdaq Global Market may provide less protection than is
accorded to investors of domestic issuers.

By contrast, under the Israeli Companies Law, shareholder
approval is required (subject to certain limited exceptions) for, among other things: (a) transactions with directors concerning the terms
of their service (including indemnification, exemption, and insurance for their service or for any other position that they may hold at
a company); (b) extraordinary transactions with controlling shareholders of publicly held companies; (c) terms of office and employment
or other engagement of a controlling shareholder, if any, or such controlling shareholder’s relative; (d) approval of transactions
with the company’s Chief Executive Officer with respect to his or her terms of employment, whether in accordance with the approved
compensation policy of the company or not, or transactions with officers of the company not in accordance with the approved compensation
policy; (e) approval of the compensation policy of the company for “office holders”(as such term is defined in the Israeli
Companies Law); and (f) certain private placements involving the issuance of 20% or more of our total voting rights, or private placements
as a result of which a person will become a controlling shareholder of the company. In addition, under the Israeli Companies Law, a merger
requires approval of the shareholders of each of the merging companies.

In addition, as a foreign private issuer, we are
exempt from the rules and regulations under the United States Securities Exchange Act of 1934, as amended, or the Exchange Act, related
to the furnishing and content of proxy statements, and our officers, directors, and principal shareholders are exempt from the reporting
and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange
Act to file annual, quarterly, and current reports, and financial statements with the SEC as frequently or as early as domestic companies
whose securities are registered under the Exchange Act.

We may lose
our foreign private issuer status which would then require us to comply with the Exchange Act’s domestic reporting regime and cause
us to incur significant legal, accounting, and other expenses.

We